CASPOFUNGIN ETEST SUSCEPTIBILITY TESTING OF CANDIDA SPECIES: RISK OF MISCLASSIFICATION OF SUSCEPTIBLE ISOLATES OF C. GLABRATA AND C. KRUSEI WHEN ADOPTING THE REVISED CLSI CASPOFUNGIN BREAKPOINTS

ARENDRUP, M.C., & PFALLER, M.A.. (2012). CASPOFUNGIN ETEST SUSCEPTIBILITY TESTING OF CANDIDA SPECIES: RISK OF MISCLASSIFICATION OF SUSCEPTIBLE ISOLATES OF C. GLABRATA AND C. KRUSEI WHEN ADOPTING THE REVISED CLSI CASPOFUNGIN BREAKPOINTS. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 56(7), 3965-3968. SID. https://sid.ir/paper/669578/en

ARENDRUP M.C., PFALLER M.A.. CASPOFUNGIN ETEST SUSCEPTIBILITY TESTING OF CANDIDA SPECIES: RISK OF MISCLASSIFICATION OF SUSCEPTIBLE ISOLATES OF C. GLABRATA AND C. KRUSEI WHEN ADOPTING THE REVISED CLSI CASPOFUNGIN BREAKPOINTS. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY[Internet]. 2012;56(7):3965-3968. Available from: https://sid.ir/paper/669578/en

M.C. ARENDRUP, and M.A. PFALLER, “CASPOFUNGIN ETEST SUSCEPTIBILITY TESTING OF CANDIDA SPECIES: RISK OF MISCLASSIFICATION OF SUSCEPTIBLE ISOLATES OF C. GLABRATA AND C. KRUSEI WHEN ADOPTING THE REVISED CLSI CASPOFUNGIN BREAKPOINTS,” ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 56, no. 7, pp. 3965–3968, 2012, [Online]. Available: https://sid.ir/paper/669578/en